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Breast cancer is the leading cause of cancer-related deaths among 
females in the developing world.[1] The South African (SA) incidence 
of breast cancer is 22.2% of all cancers, with 29.99 adjusted cases per 
10 000 per year.[2] The most recent statistics, from 2012, demonstrated 
that 9 815 women were diagnosed with breast cancer, and 3 848 died 
from the disease.[3] Breast cancer is the most prevalent type of non-
AIDS-defining cancer in HIV-positive women.[4]
The total number of persons living with HIV in SA increased from 
an estimated 4.25 million in 2002 to 7.52 million by 2018. In 2018, an 
estimated 13.1% of the total population, and approximately one-fifth 
of women of reproductive age (15 - 49 years), were HIV-positive.[5] 
According to UNAIDS (Joint United Nations Programme on HIV/
AIDS) data for 2017, 51% of people living with HIV/AIDS globally 
were female.[6] The 2017 South African National HIV Prevalence, 
Incidence and Behaviour Survey[7] revealed that, based on point 
estimates, the overall HIV peak prevalence was 31.5% in 35 - 39-year-
olds, but differed by gender (females at 39.4% and males at 23.7%) 
and peaked at an older age among males (45 - 49 years) compared 
with females (35 - 39 years).
HIV-infected individuals are at an increased risk of developing 
non-AIDS-defining cancers.[8] Despite extensive research in the 
field of HIV, data on breast cancer incidence, stage at presentation, 
response to treatment, prognosis, survival, mammographic patterns, 
histological subtypes and the role of screening in this patient 
population are limited.
In a study of breast cancer characteristics and HIV in 1 092 women 
in Soweto, SA, one-third of patients aged <50 years were HIV-
positive. These findings highlight the need for HIV testing of breast 
cancer patients, especially young patients, in HIV-endemic popula-
tions.[9]
In a study between the years 1998 and 2007 by Pantanowitz et 
al.,[10] the median age of HIV-positive patients with breast cancer was 
45 years, and most carcinomas were high-grade cancers.
In the present study, we hypothesised that specific mammographic 
features develop early in the pathogenesis of breast cancer in HIV-
positive women. We further postulated that in HIV-positive women 
who develop breast cancer, the process initially begins as a high-grade 
ductal carcinoma in situ (HGDCIS). These HIV-positive women 
are not generally included in screening programmes owing to their 
young age, so the occult pre-invasive disease is not detected and 
progresses to an invasive carcinoma. Our hypothesis is that HIV may 
be associated with HGDCIS, which is known to proceed to invasive 
breast cancer within 5 years if untreated.
Objectives
The primary objective of this study was to identify specific 
mammographic patterns and features in a cohort of HIV-positive 
patients with breast cancer and compare these features with an 
HIV-negative cohort, to determine whether the presence of certain 
mammographic features was unique to one or other of the cohorts.
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Background. Data on the association between HIV and breast cancer mammographic patterns and histological subtypes are limited.
Objectives. To determine whether specific mammographic findings, histological features and patient profiles were unique to a cohort of 
HIV-positive patients who developed breast cancer, by comparing them with a HIV-negative cohort.
Methods. This was a descriptive study in which we conducted a retrospective chart review and mammographic and pathology analysis of 
newly diagnosed breast cancer patients referred to the Addington Hospital breast clinic between August 2008 and June 2012 and entered 
into a prospective database.
Results. Thirty-eight HIV-positive and 38 HIV-negative patients were included in the study. HIV-positive patients were more likely to have 
multifocal breast cancer (p=0.007), but not multicentric disease (p=0.05). The presence of grouped and fine pleomorphic microcalcifications 
and positive HIV status demonstrated statistical significance (p=0.000). A statistically significant relationship between grouped and fine 
pleomorphic microcalcifications with biopsies confirming high-grade ductal carcinoma in situ (HGDCIS) and HIV status was demonstrated 
(p=0.001). The mean age of the HIV-positive patients was 42.5 years (p=0.000).
Conclusions. We demonstrated a statistically significant relationship between HIV status, the presence of multifocal breast cancer, and 
mammographically detected grouped and fine pleomorphic microcalcifications. A statistically significant relationship between HGDCIS 
and HIV status, and the presence of grouped and fine pleomorphic microcalcifications in HIV-positive patients with biopsies confirming 
HGDCIS, was demonstrated. Our study also showed that there is a relationship between age of presentation and HIV status.
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Secondary objectives included establishing whether there was a 
difference in the average age of presentation of the two groups and 
determining the spectrum of histology (invasive ductal or lobular 
carcinoma) of breast cancer in HIV-positive patients. We further 
investigated whether a particular histological subtype predominates, 
particularly where an associated HGDCIS is suspected based on 
certain radiological features.
Methods
This was a descriptive study in which a retrospective chart review of 
all newly diagnosed breast cancer patients referred to the Addington 
Hospital breast clinic between August 2008 and June 2012 and 
entered into a prospective database was conducted.
All patients with histologically proven breast cancer and a 
mammogram who were either known to be HIV-positive or found 
to be HIV-positive on subsequent testing were included in the study. 
A randomly selected group of HIV-negative patients formed the 
comparison group. All pathology specimens that could be traced to 
the respective patients (28 HIV-positive patients and 31 HIV-negative 
patients) were used for analysis. Male patients and HIV-positive 
patients without a mammogram (not performed owing to technical 
reasons, or missing at the time of analysis) were excluded.
Mammograms were subjected to double reading by two specialist 
radiologists with an interest in breast imaging and blinded to 
identifying patient features, in accordance with international 
guidelines (American College of Radiology Breast Imaging 
Reporting  and  Data System (BI-RADS), 2003 (4th edition)[11]). 
Since this study was conducted in 2012, and preceded the BI-RADS 
5th edition, we used the 2003 descriptive lexicon. A list of patient 
numbers was submitted to the designated anatomical pathologist, 
who independently reviewed the specimens and subsequently 
forwarded the histology results. This process reduced inter-observer 
variability of histology reports, which were previously reviewed by 
random pathologists. Breast cancers were defined as multifocal when 
more than one distinct tumour was detected in the same quadrant 
and as multicentric when multiple distinct tumours were present in 
different quadrants of the breast.
The ages of the patients were captured to analyse the average 
age at presentation. Data extracted from the double reading of the 
mammogram included characterisation of any mass lesion if present, 
the presence of variable patterns of malignant microcalcification 
(grouped, fine pleomorphic, coarse heterogeneous, fine linear and 
fine branching), the presence of multifocal and multicentric lesions, 
and the presence of lesions involving both breasts. All lesions, 
whether clinically palpable or occult, were biopsied under image 
guidance. This corresponded to the mammographically detected 
lesion. Owing to the retrospective nature of the study, it was not 
possible to determine whether all multifocal and multicentric lesions 
were biopsied. Histological analysis of the biopsy specimen from 
the mammographically documented lesion was performed, and 
the presence or absence of HGDCIS was noted. A correlation of 
histologically proven HGDCIS and the corresponding features on 
the mammogram was performed to elucidate whether the presence of 
malignant microcalcification might suggest the presence of HGDCIS.
Anonymity was maintained by the use of study numbers instead 
of patient identifiers. Each patient was allocated a study number. The 
data sheet that linked each patient to the study number was secured 
in the principal investigator (PI)’s offices, and access was limited to 
the PI (AV) and co-investigator. The computerised version was kept 
secure by password-protected access. Knowledge of patient identity 
was limited to the PI and co-investigator.
Institutional approval was obtained from the Addington Hospital 
and Inkosi Albert Luthuli Central Hospital management and the 
Uni versity of KwaZulu-Natal Biomedical Research Ethics Committee 
(ref. no. BE013/13).
Statistical analysis
The χ2 test (p<0.05) was used to assess the statistical relationship 
between the two categorical variables of HIV status and mammographic 
features. These features included the distribution of breast cancer 
(multifocal and multicentric disease) and presence of the malignant 
patterns of microcalcifications. The two-sample t-test was used to 
determine the difference in the average age of presentation of HIV-
positive and HIV-negative patients. Fisher’s exact test with a 95% 
confidence interval was applied to assess the statistical significance of 
the presence or absence of bilateral breast cancer.
Results
The initial group contained 90 HIV-positive patients; however, 
during data collection many of the mammograms were not available, 
and 52 patients were therefore excluded from the study. The study 
group comprised 38 HIV-positive patients, and the comparison 
group consisted of 38 randomly selected HIV-negative patients. Only 
28 HIV-positive and 31 HIV-negative pathology specimens were 
available in the respective arms of the study.
Using the two-sample t-test, we accepted that there was a difference 
in the average age of presentation of HIV-positive and HIV-negative 
patients, with HIV-positive patients being significantly younger than 
those who were HIV-negative (p=0.000) (Table 1).
Ten patients had mammographic features suggestive of multifocal 
breast cancer. Of these, 9 were HIV-positive. A statistically signifi-
cant relationship between HIV status and multifocal disease was 
demonstrated on χ2 analysis (p=0.007) (Table 2).
A total of 17 patients presented with mammographic features of 
multicentric breast cancer, and of these 12 were HIV-positive. In the 
assessment of multicentric disease the p-value was 0.05, which is not 
statistically significant (Table 3).
Of the 28 patients with fine pleomorphic microcalcification and 
the 26 with grouped microcalcification, 22 were HIV-positive in 
each group. In analysing the patterns of microcalcification, our 
data demonstrated statistical significance between grouped micro-
calcification (p=0.000) and fine pleomorphic microcalcification 
(p=0.000) and HIV status (Tables 4 and 5).
Twenty-eight pathology specimens from the HIV-positive group 
and 31 from the HIV-negative group were obtained for analysis 
by the independent pathologist. When the presence of HGDCIS 
was correlated with HIV status, statistical significance between the 
presence of HGDCIS and HIV status was demonstrated (p=0.012) 
(Table 6).
Using the same analysis, our data demonstrated a statistically 
significant relationship between the presence of grouped and fine 
pleomorphic microcalcifications with biopsies confirming HGDCIS 
and HIV status (p=0.001) (Table 7).
We failed to demonstrate statistical significance in the relationship 
between bilateral breast cancer and HIV status (p=0.753) (Table 8).
Table 1. Relationship between mean age and HIV status
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Discussion
A literature review failed to reveal any study that analysed the 
presence or absence of specific mammographic patterns in HIV-
positive patients with breast cancer. However, clinical practice and 
multidisciplinary meetings at our institution detected a trend in 
mammographic patterns among HIV-positive patients with breast 
cancer, prompting a retrospective analysis of the mammograms and 
pathology reports of these patients compared with an HIV-negative 
cohort. Our findings suggest that HIV-positive and HIV-negative 
patients present with different mammographic and histological 
profiles.
The primary objective of our study was to identify specific 
mammographic patterns and features in HIV-positive and HIV-
negative patients with breast cancer and to determine whether the 
presence of certain mammographic features was unique to one or 
other of the cohorts.
Table 2. Relationship between the presence of mammographic features of multifocal breast cancer and HIV status
HIV status Multifocal disease, n (%) No multifocal disease, n (%) Total, N
Positive 9 (90.0) 29 (43.9) 38
Negative 1 (10.0) 37 (56.1) 38
Total 10 (100) 66 (100) 76
Table 3. Relationship between the presence of mammographic features of multicentric breast cancer and HIV status
HIV status Multicentric disease, n (%) No multicentric disease, n (%) Total, N
Positive 12 (70.6) 26 (44.1) 38
Negative 5 (29.4) 33 (55.9) 38
Total 17 (100) 59 (100) 76
Table 4. Relationship between the presence of fine pleomorphic microcalcification and HIV status
HIV status
Fine pleomorphic microcalcification, 
n (%)
No fine pleomorphic microcalcification, 
n (%) Total, N
Positive 22 (78.6) 16 (33.3) 38
Negative 6 (21.4) 32 (66.7) 38
Total 28 (100) 48 (100) 76
Table 5. Relationship between the presence of grouped microcalcification and HIV status
HIV status Grouped microcalcification, n (%) No grouped microcalcification, n (%) Total, N
Positive 22 (84.6) 16 (32.0) 38
Negative 4 (15.4) 34 (68.0) 38
Total 26 (100) 50 (100) 76
Table 6. Prevalence of HGDCIS in HIV-positive and HIV-negative patients
HGDCIS HIV-negative, n (%) HIV-positive, n (%) Total, N
Absent 19 (61.3) 8 (28.6) 27
Present 12 (38.7) 20 (71.4) 32
Total 31 (100) 28 (100) 59
HGDCIS = high-grade ductal carcinoma in situ.
Table 7. Prevalence of grouped and fine pleomorphic microcalcifications with HGDCIS
Grouped and fine pleomorphic 
microcalcifications with HGDCIS HIV-negative, n (%) HIV-positive, n (%) Total, N
Absent 10 (83.3) 5 (25.0) 15
Present 2 (11.7) 15 (75.0) 17
Total 12 (100) 20 (100) 32
HGDCIS = high-grade ductal carcinoma in situ.
Table 8. Relationship between breast cancer and laterality
HIV status Both breasts, n (%) Single breast, n (%) Total, N
Positive 1 (50.0) 37 (50.0) 38
Negative 1 (50.0) 37 (50.0) 38
Total 2 (100) 74 (100) 76
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Our data demonstrated a statistically significant relationship between 
multifocal breast cancer and HIV status. HIV-positive patients were 
more likely to present with multifocal breast cancer compared with 
HIV-negative patients. This relationship was statistically significant 
(p=0.007).
The presence of multicentric breast cancer and breast cancer 
affecting both breasts in HIV-positive and HIV-negative patients 
failed to reach statistical significance. However, we continue to see 
a large number of multicentric breast cancers and bilateral breast 
cancers in our clinical practice. A prospective study with a more 
extensive study group and detailed record-keeping is warranted to 
investigate this association further.
The importance of distribution of disease was well demonstrated 
by Neri et al.,[12] who demonstrated that multifocal and multicentric 
disease were biologically more aggressive than unifocal tumours, had 
an increased propensity to metastatic diffusion, and were associated 
with worse outcomes. The HIV status of the patients was not 
considered as a parameter in their study. Ki-67 antigen is a marker of 
cell proliferation and is currently used as a prognostic marker in the 
management of breast cancer. Tumour biology (molecular subtype 
and Ki-67 antigen) was not captured in our study, and follow-up was 
not an end-point. It was therefore not possible for us to relate HIV 
status to more aggressive disease or a worse outcome.
With regard to patterns of microcalcification and HIV status, 
we demonstrated a statistically significant correlation between the 
presence of fine pleomorphic microcalcification (p=0.000) and 
grouped microcalcification (p=0.000) in the HIV-positive group.
The findings of grouped and fine pleomorphic microcalcifications 
were incorporated in the pathology analysis to determine whether 
these mammographic findings demonstrated any correlation with the 
pathology results and known HIV status. Our data demonstrated a 
statistically significant relationship between the presence of grouped 
and fine pleomorphic microcalcifications with biopsies confirming 
HGDCIS in HIV-positive patients (p=0.001).
Our study also demonstrated a relationship between HGDCIS and 
HIV status. Ductal carcinoma in situ (DCIS) is a heterogenous disease 
and a non-obligate precursor to invasive carcinoma. Currently there 
is controversy over the management of intermediate- and low-grade 
DCIS, with some researchers believing that it will probably never 
cause clinical disease; however, HGDCIS has been known to progress 
to invasive ductal carcinoma within 5 years if untreated. We are 
uncertain whether there is a link between HIV and the genesis of 
HGDCIS, but in our study, HIV-positive patients were more likely to 
harbour associated HGDCIS than HIV-negative patients (p=0.012), 
supporting our hypothesis of the predominance of a particular 
pre-invasive histological type (HGDCIS) in HIV-positive patients. 
These findings strengthen our hypothesis suggesting a link, but this 
postulate needs to be subjected to a larger prospective study.
The presence of mammographic features such as grouped and fine 
pleomorphic microcalcifications and the predominance of HGDCIS 
in our subset of HIV-positive patients warrant further investigation 
to determine whether HGDCIS is an obligate precursor to invasive 
duct carcinoma in HIV-positive patients.
The apparent clinical trend of HIV-positive patients presenting 
with breast cancer at a younger age than HIV-negative patients 
was analysed as a secondary objective. Our data demonstrated a 
mean age of 42.5 years in the HIV-positive group and 57.6 years in 
the HIV-negative group. Using appropriate statistical analysis, we 
accepted that there is a difference in the average age of presentation 
of HIV-positive and HIV-negative patients, with HIV-positive 
patients being significantly younger than those who were HIV-
negative (p=0.000).
Two case reports have suggested that HIV-associated breast cancer 
demonstrated atypical characteristics of earlier age of onset (36 
and 35 years of age, respectively) and marked aggressiveness of 
the cancer. [13] Voutsadakis and Silverman[14] had similar findings, 
reporting four cases demonstrating that breast cancer was more 
aggressive in HIV-positive patients than in those who were HIV-
negative. The present study did not include the characteristics of 
breast cancer, but we did assess the mean age of onset of breast cancer 
in HIV-positive and negative patients, as described above.
In one of the larger series documented to date, Hurley et al.[15] 
documented 20 HIV-positive patients with breast cancer between the 
years 1988 and 2001. In contrast to previous reports, these patients 
were older, with an average age of 44 years, and the distribution in 
terms of stage was similar to the general population.
In a study between the years 1998 and 2007, the median age 
at which breast cancer was diagnosed in HIV-positive patients 
was 45  years, and most carcinomas were of high grade.[10] In the 
ONCOVIH study of breast cancer among HIV-infected individuals, 
the median age was 43.8 years.[16] In an SA study of 1 092 women with 
breast cancer, one-third of patients aged <50 years were HIV-positive. 
These findings highlight the need for HIV testing of breast cancer 
patients, especially young patients, in HIV-endemic populations.[9] 
The most striking finding of a recent study at the Dr George Mukhari 
Academic Hospital breast clinic in Pretoria, SA,[17] concerns age 
at presentation with breast cancer, which varied according to HIV 
status: the mean (standard deviation) age at presentation in the HIV-
positive group (44.86 (9.00) years) was ~10 years younger than that in 
the HIV-negative group (53.18 (12.48) years) and that of the general 
population (54.56 (13.62) years) (p<0.0001). This finding raises the 
question whether HIV-positive patients should be screened for breast 
cancer at a younger age than the general population.[17]
Study limitations
The retrospective nature of our study and the small numbers in each 
group are significant limitations of our study.
Lack of adequate record-keeping of radiological studies and 
untraceable pathology specimens excluded a large number of patients 
from the study and resulted in the inability to link pathology results 
to 10 HIV-positive (20.8%) and 7 HIV-negative patients (15.5%) with 
available mammograms.
Histological correlation was obtained from available pathology 
specimens. We were unable to link every mammographically detected 
lesion with a pathology specimen, and consequently the descriptions 
of multifocal and multicentric lesions demonstrating malignant 
features on the mammogram were not all supported by histological 
confirmation.
An age-matched cohort analysis of the two groups was not 
performed.
Multivariate analysis was not performed to establish whether 
the mammographic features and the HGDCIS diagnosis were 
independent of age.
These limitations will be interrogated in the follow-up prospective 
study.
Conclusions
Our study demonstrated a statistically significant relationship between 
HIV status and the presence of mammographically detected multi focal 
breast cancer, and grouped and fine pleomorphic microcalcifications, 
in HIV-positive patients. We further demonstrated a statistically 
significant relationship between the presence of HGDCIS and HIV 
status, as well as the presence of HGDCIS in grouped and fine 
pleomorphic microcalcifications in HIV-positive patients.
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A prospective age-matched study with a significantly larger study 
population is required to explore the possible relationship between 
grouped and fine pleomorphic microcalcifications and high-grade 
DCIS in HIV-positive patients diagnosed with invasive breast cancer. 
An association between HGDCIS in suspicious microcalcifications 
and HIV-positive patients diagnosed with invasive breast cancer 
may have implications for screening programmes and earlier breast 
cancer detection in this high-risk population. Currently there is no 
national screening programme in SA. However, our hypothesis that 
HIV-positive patients are prone to HGDCIS requires interrogation. 
If a larger prospective study identifies a link between HIV-positive 
status and HGDCIS, guidelines to commence earlier radiographic 
screening can be designed in this cohort of patients.
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